^
    Back
    Association details:
    Biomarker:VEGFA 1154G/A
    Cancer:Diffuse Large B Cell Lymphoma
    Regimen: (cyclophosphamide + doxorubicin hydrochloride + prednisone + Rituxan (rituximab) + vincristine)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: C3 – Early Trials
    Source:
    Tumour Biol
    Title:

    Angiogenesis' related genetic variants alter clinical features and prognosis of diffuse large B-cell lymphoma patients

    Published date:
    06/17/2021
    Excerpt:
    Patients were homogeneously treated with R-CHOP...shorter event-free and overall survival were seen in patients with VEGFA -1154GA or AA genotype and VEGFA ATAGCC haplotype.
    DOI:
    10.3233/TUB-211510